Is there a ‘weight neutral’ second-generation antipsychotic for bipolar disorder?
The DOI matches its Crossref record; 67 of the 67 references it cites were found in a registry or an index.
Abstract
INTRODUCTION: Antipsychotic-induced weight gain (WG) and metabolic abnormalities are major concerns. This review was untaken to answer if there is a weight-neutral second-generation antipsychotic for bipolar disorder (BPD). Areas covered: English-language literature in MEDLINE was searched with the keywords of antipsychotic/second-generation antipsychotic or generic/brand name of second-generation antipsychotic, and BPD/mania/depression or bipolar maintenance, and safety/tolerability or WG/weight increase, and randomized, placebo-controlled trial. Difference between an antipsychotic monotherapy and placebo in absolute weight gain (AWG) and/or ≥ 7% (WG in three phases of BPD was compared based on the data from original publications. The number needed to treat to harm was used for the comparison of ≥ 7% WG. Among antipsychotics with short-term (mania and/or bipolar depression) and long-term (maintenance) studies, olanzapine, asenapine, quetiapine, risperidone had significant WG compared to placebo in both short-term and long-term trials. Aripiprazole did not cause significant WG compared to placebo in short-term studies, but caused significant WG in long-term studies. Paliperidone-ER-induced WG was significant in a mania study as measured with AWG, and ziprasidone caused significant WG in a mania study measured with ≥ 7% WG. Expert commentary: These data suggest that it is unlikely there is a weight-neutral second-generation antipsychotic in BPD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Recent reviews further suggest that asenapine and aripiprazole (longer term use) 809 also may lead to weight gain, but the impact of lurasidone on weight is minimal.810”
Citations
Cites
Overweight, Obesity, and Depression: A Systematic Review and Meta-analysis of Longitudinal Studies
Luppino, F. S., de Wit, L. M., Bouvy, P. F., Stijnen, T., Cuijpers, P., Penninx, B. W. J. H., & Zitman, F. G. (2010) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.2 · Cited by 4,322 · cited 1×
“In contrast, patients in depressive phase may gain weight from the beginning due to lack of activity, endocrine changes, and other factors [63,64].”
BackgroundTohen, M., Vieta, E., Calabrese, J., Ketter, T. A., Sachs, G., Bowden, C., Mitchell, P. B., Centorrino, F., Risser, R., Baker, R. W., et al. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.11.1079 · Cited by 908
Self-citationCalabrese, J. R., Keck, P. E., Macfadden, W., Minkwitz, M., Ketter, T. A., Weisler, R. H., Cutler, A. J., McCoy, R., Wilson, E., Mullen, J., et al. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.7.1351 · Cited by 883
Self-citationOlanzapine versus placebo in the treatment of acute mania
Tohen, M., Sanger, T. M., McElroy, S. L., Tollefson, G. D., Chengappa, K. N. R., Daniel, D. G., Petty, F., Centorrino, F., Wang, R., Grundy, S. L., et al. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.5.702 · Cited by 585
Thase, M. E., Macfadden, W., Weisler, R. H., Chang, W., Paulsson, B., Khan, A., & Calabrese, J. R. (2006) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000248603.76231.b7 · Cited by 559
Self-citationTohen, M. (2000) · Archives of General Psychiatry · doi:10.1001/archpsyc.57.9.841 · Cited by 539
Keck, P. E., Marcus, R., Tourkodimitris, S., Ali, M., Liebeskind, A., Saha, A., Ingenito, G., & Aripiprazole Study Group (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.9.1651 · Cited by 501
Almost All Antipsychotics Result in Weight Gain: A Meta-Analysis
Bak, M., Fransen, A., Janssen, J., van Os, J., & Drukker, M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0094112 · Cited by 490
Young, A. H., McElroy, S. L., Bauer, M., Philips, N., Chang, W., Olausson, B., Paulsson, B., Brecher, M., & EMBOLDEN I (Trial 001) Investigators (2010) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.08m04995gre · Cited by 390
(2004) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v65n0219 · Cited by 383
Bowden, C. L., Grunze, H., Mullen, J., Brecher, M., Paulsson, B., Jones, M., Vågerö, M., & Svensson, K. (2005) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v66n0116 · Cited by 376
Keck, P. E., Versiani, M., Potkin, S., West, S. A., Giller, E., Ice, K., & the Ziprasidone in Mania Study Group (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.4.741 · Cited by 369
Loebel, A., Cucchiaro, J., Silva, R., Kroger, H., Hsu, J., Sarma, K., & Sachs, G. (2014) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2013.13070984 · Cited by 341
McElroy, S. L., Weisler, R. H., Chang, W., Olausson, B., Paulsson, B., Brecher, M., Agambaram, V., Merideth, C., Nordenhem, A., Young, A. H., et al. (2010) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.08m04942gre · Cited by 328
Tohen, M., Calabrese, J. R., Sachs, G. S., Banov, M. D., Detke, H. C., Risser, R., Baker, R. W., Chou, J. C.-Y., & Bowden, C. L. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.2.247 · Cited by 317
Self-citationKeck, P. E., Calabrese, J. R., McQuade, R. D., Carson, W. H., Carlson, B. X., Rollin, L. M., Marcus, R. N., Sanchez, R., & Aripiprazole Study Group (2006) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v67n0414 · Cited by 290
Self-citationHirschfeld, R. M. A., Keck, P. E., Kramer, M., Karcher, K., Canuso, C., Eerdekens, M., & Grossman, F. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.6.1057 · Cited by 273
Sachs, G., Sanchez, R., Marcus, R., Stock, E., Mcquade, R., Carson, W., Abou-Gharbia, N., Impellizzeri, C., Kaplita, S., Rollin, L., et al. (2006) · Journal of Psychopharmacology · doi:10.1177/0269881106059693 · Cited by 251
Thase, M. E., Jonas, A., Khan, A., Bowden, C. L., Wu, X., McQuade, R. D., Carson, W. H., Marcus, R. N., & Owen, R. (2008) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e3181618eb4 · Cited by 251 · cited 1×
“In aripiprazole bipolar depression study [39], the completion rates of aripiprazole and placebo arms were 56.”
BackgroundThe Impact of Weight Gain on Quality of Life Among Persons With Schizophrenia
Allison, D. B., Mackell, J. A., & McDonnell, D. D. (2003) · Psychiatric Services · doi:10.1176/appi.ps.54.4.565 · Cited by 245
Scherk, H., Pajonk, F. G., & Leucht, S. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.4.442 · Cited by 243
Keck, P. E., & Calabrese, J. R. (2007) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v68n1003 · Cited by 238
Self-citationMcIntyre, R. S., Brecher, M., Paulsson, B., Huizar, K., & Mullen, J. (2005) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2005.02.006 · Cited by 227
Gao, K., Kemp, D. E., Ganocy, S. J., Gajwani, P., Xia, G., & Calabrese, J. R. (2008) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e318166c4d5 · Cited by 216
Self-citationDurgam, S., Earley, W., Lipschitz, A., Guo, H., Laszlovszky, I., Németh, G., Vieta, E., Calabrese, J. R., & Yatham, L. N. (2016) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2015.15020164 · Cited by 209
Self-citationRisperidone Long-Acting Injectable Monotherapy in the Maintenance Treatment of Bipolar I Disorder
Quiroz, J. A., Yatham, L. N., Palumbo, J. M., Karcher, K., Kushner, S., & Kusumakar, V. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.01.015 · Cited by 200
Smulevich, A. B., Khanna, S., Eerdekens, M., Karcher, K., Kramer, M., & Grossman, F. (2005) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2004.06.003 · Cited by 192
McIntyre, R. S., Cohen, M., Zhao, J., Alphs, L., Macek, T. A., & Panagides, J. (2009) · Bipolar Disorders · doi:10.1111/j.1399-5618.2009.00748.x · Cited by 189
Risperidone in the treatment of acute mania: Double-blind, placebo-controlled study
Khanna, S., Vieta, E., Lyons, B., Grossman, F., Eerdekens, M., & Kramer, M. (2005) · British Journal of Psychiatry · doi:10.1192/bjp.187.3.229 · Cited by 188
Suppes, T. M., Datto, C. J., Minkwitz, M. C., Nordenhem, A., Walker, C., & Darko, D. F. (2009) · Journal of Affective Disorders · doi:10.1016/j.jad.2009.10.007 · Cited by 183
Keck, P. E., Orsulak, P. J., Cutler, A. J., Sanchez, R., Torbeyns, A., Marcus, R. N., McQuade, R. D., & Carson, W. H. (2009) · Journal of Affective Disorders · doi:10.1016/j.jad.2008.05.014 · Cited by 172
Weight gain in bipolar disorder: pharmacological treatment as a contributing factor
Torrent, C., Amann, B., Sánchez‐Moreno, J., Colom, F., Reinares, M., Comes, M., Rosa, A. R., Scott, J., & Vieta, E. (2008) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2008.01204.x · Cited by 169
McIntyre, R. S., Cohen, M., Zhao, J., Alphs, L., Macek, T. A., & Panagides, J. (2010) · Journal of Affective Disorders · doi:10.1016/j.jad.2009.12.028 · Cited by 162
Potkin, S. G., Keck, P. E., Segal, S., Ice, K., & English, P. (2005) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000169068.34322.70 · Cited by 159
Ballenger, J. C. (2011) · Yearbook of Psychiatry and Applied Mental Health · doi:10.1016/j.ypsy.2010.10.088 · Cited by 146
Bowden, C. L., Vieta, E., Ice, K. S., Schwartz, J. H., Wang, P. P., & Versavel, M. (2010) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.09m05482yel · Cited by 144
Durgam, S., Starace, A., Li, D., Migliore, R., Ruth, A., Németh, G., & Laszlovszky, I. (2015) · Bipolar Disorders · doi:10.1111/bdi.12238 · Cited by 130
Vieta, E., Montgomery, S., Sulaiman, A. H., Cordoba, R., Huberlant, B., Martinez, L., & Schreiner, A. (2012) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2012.03.004 · Cited by 130
Tohen, M., McDonnell, D. P., Case, M., Kanba, S., Ha, K., Fang, Y. R., Katagiri, H., & Gomez, J.-C. (2012) · British Journal of Psychiatry · doi:10.1192/bjp.bp.112.108357 · Cited by 128
Sachs, G. S., Greenberg, W. M., Starace, A., Lu, K., Ruth, A., Laszlovszky, I., Németh, G., & Durgam, S. (2015) · Journal of Affective Disorders · doi:10.1016/j.jad.2014.11.018 · Cited by 127
Vieta, E., Mullen, J., Brecher, M., Paulsson, B., & Jones, M. (2005) · Current Medical Research and Opinion · doi:10.1185/030079905x46340 · Cited by 123
Vieta, E., Nuamah, I. F., Lim, P., Yuen, E. C., Palumbo, J. M., Hough, D. W., & Berwaerts, J. (2010) · Bipolar Disorders · doi:10.1111/j.1399-5618.2010.00815.x · Cited by 122
Calabrese, J. R., Keck, Jr., Starace, A., Lu, K., Ruth, A., Laszlovszky, I., Németh, G., & Durgam, S. (2015) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.14m09081 · Cited by 121
Self-citationYoung, A. H., Oren, D. A., Lowy, A., McQuade, R. D., Marcus, R. N., Carson, W. H., Spiller, N. H., Torbeyns, A. F., & Sanchez, R. (2009) · British Journal of Psychiatry · doi:10.1192/bjp.bp.108.049965 · Cited by 109
Berwaerts, J., Melkote, R., Nuamah, I., & Lim, P. (2012) · Journal of Affective Disorders · doi:10.1016/j.jad.2012.01.047 · Cited by 101
Tohen, M., Vieta, E., Goodwin, G. M., Sun, B., Amsterdam, J. D., Banov, M., Shekhar, A., Aaronson, S. T., Bardenstein, L., Grecu-Gabos, I., et al. (2008) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v69n1113 · Cited by 87
Vieta, E., Ramey, T., Keller, D., English, P., Loebel, A., & Miceli, J. (2010) · Journal of Psychopharmacology · doi:10.1177/0269881108099418 · Cited by 77
Gao, K., Ganocy, S. J., Gajwani, P., Muzina, D. J., Kamp, D. E., & Calabrese, J. R. (2008) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v69n0217 · Cited by 74
Self-citationBerwaerts, J., Xu, H., Nuamah, I. F., Lim, P., & Hough, D. W. (2010) · Journal of Affective Disorders · doi:10.1016/j.jad.2010.06.030 · Cited by 68
Emerging drugs for schizophrenia: an update
Köster, L.-S., Carbon, M., & Correll, C. U. (2014) · Expert Opinion on Emerging Drugs · doi:10.1517/14728214.2014.958148 · Cited by 52
Mallakh, R. S. E., Vieta, E., Rollin, L., Marcus, R. N., Carson, W. H., & McQuade, R. D. (2010) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2010.07.003 · Cited by 48
Cutler, A. J., Datto, C. J., Nordenhem, A., Minkwitz, M. C., Acevedo, L. D., & Darko, D. F. (2011) · Clinical Therapeutics · doi:10.1016/j.clinthera.2011.10.002 · Cited by 48
Balancing benefits and harms of treatments for acute bipolar depression
Ketter, T. A., Miller, S., Dell'Osso, B., Calabrese, J. R., Frye, M. A., & Citrome, L. (2014) · Journal of Affective Disorders · doi:10.1016/s0165-0327(14)70006-0 · Cited by 47
Self-citationYoung, A. H., McElroy, S. L., Olausson, B., Paulsson, B., (D1447C00001), O. B. O. T. E. I., & Embolden II (D1447C00134) Investigators (2014) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2012.665177 · Cited by 46
Weight gain and metabolic issues of medicines used for bipolar disorder
Fagiolini, A. M., & Chengappa, K. N. R. (2007) · Current Psychiatry Reports · doi:10.1007/s11920-007-0071-1 · Cited by 36
Katagiri, H., Takita, Y., Tohen, M. F., Higuchi, T., Kanba, S., & Takahashi, M. (2011) · Journal of Affective Disorders · doi:10.1016/j.jad.2011.10.045 · Cited by 35
Tarr, G. P., Glue, P., & Herbison, P. (2010) · Journal of Affective Disorders · doi:10.1016/j.jad.2010.11.009 · Cited by 32
Kanba, S., Kawasaki, H., Ishigooka, J., Sakamoto, K., Kinoshita, T., & Kuroki, T. (2014) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2012.669047 · Cited by 31
Wang, Z., Kemp, D. E., Chan, P. K., Fang, Y., Ganocy, S. J., Calabrese, J. R., & Gao, K. (2010) · The International Journal of Neuropsychopharmacology · doi:10.1017/s146114571000101x · Cited by 28
Self-citationLipkovich, I. A., Jacobson, J. G., Caldwell, C., Hoffmann, V. P., Kryzhanovskaya, L. A., & Beasley, C. M. (2025) · Psychopharmacology Bulletin · doi:10.64719/pb.4081 · Cited by 21
Clinical Risk Factors for Weight Gain During Psychopharmacologic Treatment of Depression
Kloiber, S. M., Domschke, K., Ising, M., Arolt, V., Baune, B. T., Holsboer, F., & Lucae, S. (2015) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.14m09212 · Cited by 19
Gao, K., Yuan, C., Wu, R., Chen, J., Wang, Z., Fang, Y., & Calabrese, J. R. (2015) · Neuroscience Bulletin · doi:10.1007/s12264-014-1534-0 · Cited by 19
Self-citationGao, K., Pappadopulos, E. A., Karayal, O. N., Kolluri, S., & Calabrese, J. R. (2013) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e3182917f3f · Cited by 17
Self-citationSocial Consequences of Obesity
Puhl, R. M., Henderson, K. E., & Brownell, K. D. (2005) · Wiley eBooks · doi:10.1002/9780470987087.ch3 · Cited by 13
Gao, K., Kemp, D. E., Wu, R., & Calabrese, J. R. (2015) · Wiley eBooks · doi:10.1002/9781118753378.ch105 · Cited by 9
Self-citationGao, K., Kemp, D. E., & Calabrese, J. R. (2009) · Birkhäuser Basel eBooks · doi:10.1007/978-3-7643-8567-5_10 · Cited by 7
Self-citationPharmacological Treatment Bipolar Depression
Gao, K., Wu, R., Grunze, H., & Calabrese, J. R. (2015) · Oxford University Press eBooks · doi:10.1093/med/9780199300532.003.0022 · Cited by 3
Self-citation
Research works printed but not linked: 3
- Lipkovich I, 2009, Psychopharmacol Bull, 42, 23
- Gao K, Milestones in drug therapy series (M Parnham, J Bruinvels, series eds), bipolar depression: molecular neurobiology, clinical diagnosis, and pharmacotherapy
- Gao K, 2015, Neurosci, 31, 572
Cited by
Yatham, L. N., Kennedy, S. H., Parikh, S. V., Schaffer, A., Bond, D. J., Frey, B. N., Sharma, V., Goldstein, B. I., Rej, S., Beaulieu, S., et al. (2018) · Bipolar Disorders · doi:10.1111/bdi.12609 · Cited by 1,852
Self-citationVieta, E., Berk, M., Schulze, T. G., Carvalho, A. F., Suppes, T., Calabrese, J. R., Gao, K., Miskowiak, K. W., & Grande, I. (2018) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2018.8 · Cited by 891
Self-citationDouble-blind, placebo-controlled trial of pioglitazone for bipolar depression
Aftab, A., Kemp, D. E., Ganocy, S. J., Schinagle, M., Conroy, C. M., Brownrigg, B., D’Arcangelo, N., Goto, T., Woods, N., Serrano, M. B., et al. (2018) · Journal of Affective Disorders · doi:10.1016/j.jad.2018.11.090 · Cited by 45
Self-citationGao, K., Fang, F., Wang, Z., & Calabrese, J. R. (2016) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000000596 · Cited by 21
Self-citationYaramala, S. R., McElroy, S. L., Geske, J. R., Winham, S. J., Gao, K., Reilly-Harrington, N. A., Ketter, T. A., Deckersbach, T., Kinrys, G., Kamali, M., et al. (2018) · Journal of Affective Disorders · doi:10.1016/j.jad.2018.09.025 · Cited by 23
Self-citation
Metadata
- Authors
- Fang, F., Wang, Z., Wu, R., Calabrese, J. R., & Gao, K.
- Affiliations
- Shanghai Mental Health Center (CN)
- Central South University (CN)
- University Hospitals of Cleveland (US)
- Corresponding author
- Wang, Zuowei
- Gao, Keming
- Venue
- Expert Review of Neurotherapeutics
- Publisher
- Informa UK Limited
- Published
- 2017-01-02
- Volume
- 17
- Issue
- 4
- Pages
- 407-418
- ISSN
- 1473-7175 (ISSN-L)
- 1744-8360
- OpenAlex
- W2564477552
- Cited by
- 18
- References
- 67
- Citations by year
- 2026: 1 · 2025: 1 · 2023: 1 · 2022: 1 · 2021: 2 · 2020: 1 · 2019: 3 · 2018: 6 · 2017: 1
- FWCI
- 0.52
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Expert Review of Neurotherapeutics (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Natural Science Foundation of China (81301159)
- Shanghai Key Medicine Specialties Program (ZK2012A12)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Keywords
- bipolar disorder, atypical antipsychotics, antipsychotic-induced weight gain, aripiprazole, olanzapine, asenapine, quetiapine, risperidone, ziprasidone, metabolic side effects, mania, bipolar depression
- MeSH terms
- Olanzapine, Benzodiazepines, Bipolar Disorder, Humans, Antipsychotic Agents, Risperidone
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.